University of Hertfordshire

By the same authors

Towards host-directed therapies for tuberculosis

Research output: Contribution to journalComment/debate

  • Alimuddin Zumla
  • Markus Maeurer
  • Jeremiah Chakaya
  • Michael Hoelscher
  • Francine Ntoumi
  • Roxana Rustomjee
  • Cristina Vilaplana
  • Dorothy Yeboah-Manu
  • Voahangy Rasolof
  • Paula Munderi
  • Nalini Singh
  • Eleni Aklillu
  • Nesri Padayatchi
  • Eusebio Macete
  • Nathan Kapata
  • Modest Mulenga
  • Gibson Kibiki
  • Sayoki Mfinanga
  • Thomas Nyirenda
  • Leonard Maboko
  • Alberto Garcia-Basteiro
  • Niaina Rakotosamimanana
  • Matthew Bates
  • Peter Mwaba
  • Klaus Reither
  • Sebastien Gagneux
  • Sarah Edwards
  • Elirehema Mfinanga
  • Salim Abdulla
  • Pere-Joan Cardona
  • James B W Russell
  • Vanya Gant
  • Mahdad Noursadeghi
  • Paul Elkington
  • Maryline Bonnet
  • Clara Menendez
  • Tandakha N Dieye
  • Bassirou Diarra
  • Almoustapha Maiga
  • Abraham Aseffa
  • Shreemanta Parida
  • Christian Wejse
  • Eskild Petersen
  • Pontiano Kaleebu
  • Matt Oliver
  • Gill Craig
  • Tumena Corrah
  • Leopold Tientcheu
  • Martin Antonio
  • Martin Rao
  • Host-Directed Therapies Network
View graph of relations
Original languageEnglish
Number of pages2
Pages (from-to)511-2
JournalNature reviews. Drug discovery
Journal publication dateAug 2015
Volume14
Issue8
DOIs
Publication statusPublished - Aug 2015

Abstract

The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.

ID: 11298671